Imcivree

Active Ingredient(s): Setmelanotide
FDA Approved: * November 25, 2020
Pharm Company: * RHYTHM PHARMACEUTICALS INC
Category: Diet / Weight Loss

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Imcivree Overview

Setmelanotide, sold under the brand name Imcivree, is a medication used for the treatment of genetic obesity.[1][2][3] The most common side effects include injection site reactions, skin hyperpigmentation (skin patches that are darker than surrounding skin), headache and gastrointestinal side effects (such as nausea, diarrhea, and abdominal pain), among others.[2] Spontaneous penile erections in males and adverse sexual reactions...

Read more Imcivree Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Setmelanotide

Recent Imcivree Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Setmelanotide
  • Solution: 10mg/ml, 10mg/ml (10mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Setmelanotide or a similar ingredient: (1 result)